Breakthrough cancer medicine and its impact on novel drug development in China:report of the US Chinese Anti-Cancer Association (USCACA) and Chinese Society of Clinical Oncology (CSCO) Joint Session at the 17th CSCO Annual Meeting
文献类型：期刊论文
| 作者 | Luo Feng Roger1; Ding Jian2 ; Chen Helen X1; Liu Hao3; Fung Mancheong4; Koehler Maria5; Armand Jean Pierre6; Jiang Lei2; Xu Xiao1; Zhang Ge7
|
| 刊名 | Chinese Journal of Cancer
 |
| 出版日期 | 2014 |
| 卷号 | 33期号:12页码:620 |
| 关键词 | CELL LUNG-CANCER GASTRIC-CANCER BREAST-CANCER INHIBITOR PCI-32765 IBRUTINIB Breakthrough clinical trial cancer medicine |
| ISSN号 | 1000-467X |
| DOI | 10.5732/cjc.014.10246 |
| 英文摘要 | The US Chinese Anti-Cancer Association (USCACA) teamed up with Chinese Society of Clinical Oncology (CSCO) to host a joint session at the 17th CSCO Annual Meeting on September 20th, 2014 in Xiamen, China. With a focus on breakthrough cancer medicines, the session featured innovative approaches to evaluate breakthrough agents and established a platform to interactively share successful experiences from case studies of 6 novel agents from both the United States and China. The goal of the session is to inspire scientific and practical considerations for clinical trial design and strategy to expedite cancer drug development in China. A panel discussion further provided in-depth advice on advancing both early and full development of novel cancer medicines in China. |
| 语种 | 英语 |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/285505]  |
| 专题 | 中国科学院上海药物研究所 |
| 作者单位 | 1.The US Chinese Anti-Cancer Association 2.中国科学院上海药物研究所 3.Novartis Pharmaceuticals Oncology 4.Department of Oncology, Janssen Research & Development, LLC 5.Pfizer Oncology 6.Institut Gustave Roussy, Cancer Campus Grand Paris, 114 rue Edouard-Vaillant 7.Jiangsu Hengrui Medicine Co., Ltd. |
| 推荐引用方式 GB/T 7714 | Luo Feng Roger,Ding Jian,Chen Helen X,et al. Breakthrough cancer medicine and its impact on novel drug development in China:report of the US Chinese Anti-Cancer Association (USCACA) and Chinese Society of Clinical Oncology (CSCO) Joint Session at the 17th CSCO Annual Meeting[J]. Chinese Journal of Cancer,2014,33(12):620. |
| APA | Luo Feng Roger.,Ding Jian.,Chen Helen X.,Liu Hao.,Fung Mancheong.,...&Yan Li.(2014).Breakthrough cancer medicine and its impact on novel drug development in China:report of the US Chinese Anti-Cancer Association (USCACA) and Chinese Society of Clinical Oncology (CSCO) Joint Session at the 17th CSCO Annual Meeting.Chinese Journal of Cancer,33(12),620. |
| MLA | Luo Feng Roger,et al."Breakthrough cancer medicine and its impact on novel drug development in China:report of the US Chinese Anti-Cancer Association (USCACA) and Chinese Society of Clinical Oncology (CSCO) Joint Session at the 17th CSCO Annual Meeting".Chinese Journal of Cancer 33.12(2014):620. |
入库方式： OAI收割
来源：上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。